Search Results - "Alkhattabi, Abdullah"

Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation by Koch, Sheryl E, Mann, Adrien, Jones, Shannon, Robbins, Nathan, Alkhattabi, Abdullah, Worley, Mariah C, Gao, Xu, Lasko-Roiniotis, Valerie M, Karani, Rajiv, Fulford, Logan, Jiang, Min, Nieman, Michelle, Lorenz, John N, Rubinstein, Jack

“…OBJECTIVE:Hypertension (increased afterload) results in cardiomyocyte hypertrophy leading to left ventricular hypertrophy and subsequently, heart failure with…”
Get full text

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials by Hegazi, Omar E, Alalalmeh, Samer O, Alnuaimi, Ghala Rashid Humaid, Shahwan, Moyad, Jairoun, Ammar Abdulrahman, Alorfi, Nasser M, Majrashi, Shaker A, Alkhanani, Mustfa Faisal, Alkhattabi, Abdullah, Alourfi, Mansour M, Alsolami, Faris A, Alsharif, Saeed, Alshahrani, Hatim

“…Nonalcoholic Fatty Liver Disease (NAFLD) has become a significant public health concern, affecting approximately one-fourth of the population. Despite its…”
Get full text

Tu1075 THE ROLE OF ENDOSCOPIC HEMOSTATIC POWDER IN NON-VARICEAL GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW ANS META-ANALYSIS WITH IMPLICATION ON CLINICAL PRACTICE by Bukhari, Majidah A., Aljehani, Mohannad A., El Zein, Mohamad H., Qatomah, Abdulrahman, Haito-Chavez, Yamile, Sabbagh, Waad A., Alkandari, Asma A., Alkhattabi, Abdullah, Ghunaim, Monther, Alrajhi, Abdullah s., Al omar, Haneen Y., Ibrahim, Mostafa, Khashab, Mouen A.

Get full text

Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis by Hegazi, Omar E, Alalalmeh, Samer O, Shahwan, Moyad, Jairoun, Ammar Abdulrahman, Alourfi, Mansour M, Bokhari, Ghfran Abdulrahman, Alkhattabi, Abdullah, Alsharif, Saeed, Aljehani, Mohannad Abdulrahman, Alsabban, Abdulmalik Mohammed, Almtrafi, Mohammad, Zakri, Ysear Abdulaziz, AlMahmoud, Abdullah, Alghamdi, Khalid Mohammed, Ashour, Ahmed M, Alorfi, Nasser M

“…Non-alcoholic fatty liver disease (NAFLD) is a common disease and has been increasing in recent years. To date, no FDA-approved drug specifically targets…”
Get full text

Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry by Alorfi, Nasser M, Alourfi, Mansour M, Bokhari, Ghfran Abdulrahman, Alkhattabi, Abdullah, Ibrahim, Nihal Abdalla, Alsabban, Abdulmalik Mohammed, Almatrafi, Mohammad J, Zakri, Yaser Abdulaziz, Almahmoud, Abdullah Jasem, Al-Ghamdi, Khalid Mohammed A, Alsharif, Saeed Nasser

“…Background: Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic inflammatory conditions affecting the…”
Get full text

Bovine jugular vein valved xenograft for extracardiac total cavo‐pulmonary connection: The risk of thrombosis and the potential liver protection effect by Ismail, Mohamed F., Elmahrouk, Ahmed F., Arafat, Amr A., Hamouda, Tamer E., Edrees, Azzahra, Bogis, Abdulbadee, Arfi, Amin M., Dohain, Ahmed M., Alkhattabi, Abdullah, Alharbi, Ahmed W., Shihata, Mohammad S., Al‐Radi, Osman O., Al‐Ata, Jameel A., Jamjoom, Ahmed A.

“…Background Currently, non‐valved conduits are preferred for extracardiac total cavo‐pulmonary connection (TCPC). However, previous work has failed to provide…”
Get full text